Delft's medical sales rise despite reorganisation
This article was originally published in Clinica
Executive Summary
Dutch defence and high-tech group Delft Instruments has reported a 6% increase in the sales of its medical business to Fl 286 million ($172 million). Delft attributes this to a recovery in its Oldelft division, further growth at Oldelft Benelux and modest growth at Nucletron. Sales at the Enraf-Nonius division fell slightly.